Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amway on China

This article was originally published in The Rose Sheet

Executive Summary

Without a U.S. normal trade relations status designation for China, tariffs on domestic imports could increase 30% to 50%, Chairman Steve Van Andel states in comments before the House Ways & Means/Trade Subcommittee June 8. Van Andel spoke on behalf of the U.S. Chamber of Commerce to urge the committee to normalize trade relations with China and support its accession to the World Trade Organization. The U.S./China trade agreement, signed April 10, would lift the direct sales ban in China by 2003 ("The Rose Sheet" April 19, p. 9). The agreement remains subject to approval by Congress and President Clinton. Amway China, which commenced operations in 1995, is one of the country's largest investors, with 1997 consolidated sales of $178 mil. and over 500,000 Chinese distributors. Amway has invested $100 mil. in China over the past five years ("The Rose Sheet" June 15, 1998, p. 4)

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel